Objective: During the postmenopausal period, visceral fat tissue is responsible not only for increased cardiometabolic risk, but also for endocrine function leading to increased endometrial thickness (ET). The current study aimed to 1) determine the predictive value of ultrasonographic visceral fat thickness (VFT) and the visceral adiposity index (VAI), which is defi ned as «an indicator of visceral adipose function,» for the prediction of an ET>5 mm and 2) to search for a correlation between these two measures.
Introduction
The risk of cardiovascular diseases (CVD) and metabolic syndrome (MS) increase during the post-menopausal period [1] . Obesity is a component of MS. Increased adipose tissue is not only a storage compartment of unconsumed energy, but also a contributor of several factors involved in endocrine regulation and increased insulin resistance [1, 2] . Furthermore, increased adipose tissue is the primary source of circulating estrogen, which is synthesized by its androgen precursors, and is also responsible for increased endometrial thickness (ET) and CVD during the post-menopausal period [3] [4] [5] .
Body fat distribution plays more of a role in increased ET than tissue fat amount [5] . Visceral fat mass, a component of abdominal fat accumulation that is particularly typical of the postmenopausal period, leads to MS and increased ET [5, 6] .
Although the measurement of waist circumference (WC) is an easy-to-measure marker of visceral fat tissue, it has a low specifi city [7] . WC not only measures visceral fat tissue, but also subcutaneous fat tissue, which is another component of abdominal fat mass [5] . In other words, women with the same WC value may have signifi cantly different visceral fat measurements [7] . Recently, it has been demonstrated that the ultrasonographic measurement of visceral fat thickness (VFT) is an inexpensive, practical, reproducible, easily accessible technique that is correlated with reliable scanning methods such as computerized tomography [8] . In addition, the visceral adiposity index (VAI), a mathematical model that uses body mass index (BMI), WC, triglyceride (TG) and high density lipoprotein (HDL) parameters, is a sensitive marker of visceral obesity that is known to be a valuable indicator of "visceral adipose function" and insulin sensitivity. It is claimed that increased VAI levels are strongly associated with cardiometabolic risk [9] .
There exists a positive correlation between ET increase and abnormal endometrial conditions. When an endometrial thickness of 5 mm is accepted as a cutoff value for endometrial pathology in the post-menopausal period, endometrial cancers and atypical endometrial hyperplasias can be detected with a sensitivity of 80.5% and a specifi city of 86.2% [10] . Currently, the literature includes certain studies that suggest a correlation between body fat distribution and ET, yet the role of the former in the determination of an ET greater than 5 mm remains unclear [5, 7, 11] .
This study aims to determine whether easily calculable VAI values and VFT measurements, which do not cause as much irritation as transvaginal ultrasonography, possess adequate predictive power in relation to ETs of greater than 5 mm during the postmenopausal period. In addition, this study also seeks to determine if these parameters are interrelated. 
Materials and Methods

Anthropometric and metabolic measurements
The participants' weights and heights were measured 
Ultrasonographic evaluation
A high resolution ultrasonographic system (Aplio 500;
Toshiba, Toshigi, Japan) was used for ultrasonographic 
Statistical analysis
The statistical package SPSS (Statistical Package for Social Sciences; SPSS Inc., Chicago, IL) for Windows 16 .0 was used to analyze the data. A Mann-Whitney U test was used to compare between the EM>5mm and EM≤5mm groups. Mean and standard deviations were used to describe the data. Pearson's correlation coeffi cient was used for evaluating the relationships between the metabolic and anthropometric measurements, as well as the ultrasonographic measurements and VAI. A p value of 0.05 or less was considered to be statistically signifi cant.
Results
This study included 79 women in total. Fifteen of the seventy-nine women in the study sample had an ET>5 mm.
The basic characteristics of the ET≤5mm and ET>5mm groups are presented in table 1. The ET>5mm group had higher BMI and HC measurements than ET≤5mm group (p=0.03). The two groups did not differ with respect to VAI and VFT (p=0.95 and p=0.08).
Considering all postmenopausal women, only HC (p=0.02) and VFT (p=0.05) were positively correlated to ET. On the other hand, VAI had a negative correlation with HDL (p<0.001) and a positive correlation with TG (p<0.001) and VFT (p=0.03). VFT showed had a positive correlation with TG (p=0.003), time since menopause (p=0.03), anthropometric measurements BMI (p<0.001), WC (p=0.008) and HC (p=0.01) ( Table 2) .
Discussion
To our knowledge, we have investigated for the fi rst time in the literature both the feasibility of VAI as a simple mathematical formula and VFT as a measurement of fat tissue thickness, which is thought to be an endocrine function responsible for estrone increase, in the prediction of ET increase, as well as the relationship between these two measurements. As a result, we found that neither of the two measurements had any predictive value for an ET>5mm. As the VAI increased, ultrasonographic VFT measurement similarly increased.
An increase in BMI has been linked to a parallel increase in ET [13] . Abdominal fat accumulation is typical in the postmenopausal period. This type of lipoidosis is thought to be the most effective fat accumulation in increased ET and CVD risk [5, 14] . Warming et al. [5] , studied the body fat distributions of 531 healthy postmenopausal women using dual energy x-ray absorptiometry and found that visceral fat tissue was the primary factor in the production of estrone via the conversion of androgen precursors, arguing it to be the most effective fat tissue on endometrial thickness. Subsequent studies also support the notion that subcutaneous and visceral fat tissues have separate endocrinological functions [11] . Body fat distribution affects the plasma levels of sex hormones. Compared to other types of lipoidosis, abdominal lipoidosis is characterized by lower levels of sex hormone binding protein (SHBG), which in turn increases free estrogen levels, leading to enhanced ET thickness [15] . Higher insulin levels due to insulin resistance cause reduced SHBG levels [16] .
Abdominal lipoidosis, which is typical during menopause, leads to increased CVD and MS risks [14] . The increased concentration of free fatty acids and enhanced adipokine secretion as a result of increased visceral fat content have been shown to lead to insulin resistance [17] . Increased insulin levels not only cause an increase in free estrogen by decreasing SHBG, but also an insulin growth factor (IGF)-1 that activates endometrial cell growth and IGF-binding protein-1 [18] . Hence, fat tissue can 
